“…Some immunohistochemical markers, such as p53, p21, bcl-2, AMACR (alpha methyl-CoA racemase), can be used to sustain a morphologic diagnosis of dysplasia [1,29]. Considering that treatment for UC-associated dysplasia is usually colectomy and there is a poor inter-and intraobserver agreement, especially for the diagnosis of LGD, it is mandatory that the diagnosis is confirmed by an independent expert pathologist before any invasive therapy [34][35][36].…”